Hayashi, K., Nagasaki, E., Kan, S., Ito, M., Kamata, Y., Homma, S., & Aiba, K. (2016). Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation. Cancer Sci.
Citação norma ChicagoHayashi, Kazumi, Eijiro Nagasaki, Shin Kan, Masaki Ito, Yuko Kamata, Sadamu Homma, and Keisuke Aiba. "Gemcitabine Enhances Rituximab‐mediated Complement‐dependent Cytotoxicity to B Cell Lymphoma By CD20 Upregulation." Cancer Sci 2016.
Citação norma MLAHayashi, Kazumi, et al. "Gemcitabine Enhances Rituximab‐mediated Complement‐dependent Cytotoxicity to B Cell Lymphoma By CD20 Upregulation." Cancer Sci 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.